Skip to main content
. 2024 Aug 19;19(8):e0307101. doi: 10.1371/journal.pone.0307101

Table 3. HIV and HBV seroreactivity according to socio-demographic data.


Variables
HIV HBV
Number* Positive (%)* OR 95% CI P-value Number* Positive (%)* OR 95% CI P-value
Sex Male1 30,872 858 (2,8) -
0,026–0,029
0.0002
59,709 4,735 (7.9) 1.81 1.7–2.0 0.0001
Female 6,327 333 (5,3) 1.89 1.7–2.2
18,083 794 (4.4) - 0.04–0.05
Age 18–24 12,324 328 (2,7) - 0.24–0.03
-
29,068 1,781 (6.1) 1.21 1.03–1.4 0.017
25–34
35–44
16,679 501 (3,0) 1.12 0.98–1.3
0.093
33,561 2,679 (8.0) 1.57 1.3–1.8 0.0001
6,549 303 (4,6) 1.73
1.5–2.0 0.0002
11,702 894 (7.6) 1.51 1.3–1.8 0.0001
≥45 1,647 59 (3,6)
1.34 1.01–1.8 0.038 3,461 175 (5.1) - 0.04–0.06 -
Type of blood donor
Volunteer1
Family

9,599

245 (2,6)

-

0.023–0.029

0.0002

25,980

1,592 (6.1)

-

0.06–0.064

0.0001

27,600

946 (3,4)

1.34

1.2–1.5

51,812

3,937 (7.6)

1.24

1.2–1.3

*Studies that provided data on HIV and HBV seroreactivity according to sociodemographic data have been included in this table.

1Group of reference; OR : Odds Ratio ; 95% CI: 95% Confidence Interval.